Gene expression profiling as a noninvasive method to monitor for cardiac allograft rejection.
D054598:Blue Cross Blue Shield Insurance Plans; D020869:Gene Expression Profiling; D006084:Graft Rejection / Q000175:diagnosis*; D016027:Heart Transplantation / Q000009:adverse effects*; D006801:Humans; D008991:Monitoring, Physiologic / Q000379:methods*; D017063:Outcome Assessment, Health Care; D011183:Postoperative Complications; D013673:Technology Assessment, Biomedical; D014184:Transplantation, Homologous; D014481:United States; D014486:United States Food and Drug Administration